NOVOCURE INC.

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

6 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $780,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. Everything on this page is grouped by the registrant's LDA id (401106408), not by name.

Clients 1

NOVOCURE INC. $780,000 6 filings

Lobbyists named 2

ELLE WHITSON 6 filings · through 2026 Covered Ofﬁcial Positions Continued: Health Policy Advisor, Congresswoman Cathy McMorris Rogers; Staff Assistant / Legislative Correspondent / Legislative Assi…
KATHERINE MEYER 6 filings · through 2026 Senior Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senato…

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

Reported by year 2 years

2026 $340,000 2 filings
2025 $440,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

Health & Human Services, Dept of (HHS) 6
HOUSE OF REPRESENTATIVES 6
SENATE 6
Commerce, Dept of (DOC) 1
U.S. Trade Representative (USTR) 1

Recent filings 6 total

Q2

NOVOCURE INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $160,000 expenses · posted Jul 19, 2026

View → Q1

NOVOCURE INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $180,000 expenses · posted Apr 20, 2026

View → Q4

NOVOCURE INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $110,000 expenses · posted Jan 17, 2026

View → Q3

NOVOCURE INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $110,000 expenses · posted Oct 13, 2025

View → Q2

NOVOCURE INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $110,000 expenses · posted Jul 15, 2025

View → Q1

NOVOCURE INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $110,000 expenses · posted Apr 16, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.